Impact Therap-b (7630.HK) Earnings Analysis
Impact Therap-b (7630.HK) has no confirmed upcoming earnings date. Trailing P/E -9.39.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 7630.HK next report earnings?
No confirmed upcoming earnings date is currently scheduled for 7630.HK. This page updates as the calendar is published.
7630.HK earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
7630.HK valuation and analyst view
| Trailing P/E | -9.39 |
|---|---|
| Trailing EPS | -0.14893 HKD |
| Price / book | -3.10 |
| Dividend yield | 0.00% |
| Market cap | 3.24B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Impact Therap-b (7630.HK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 7630.HK. This page updates as the calendar is published.
What is 7630.HK's current P/E ratio and EPS?
7630.HK trades at a trailing P/E of -9.39 on trailing EPS of -0.1489252173147276 HKD.
What do analysts rate 7630.HK?
7630.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.